This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Barclays Remains a Buy on JBS (JBS)
Barclays analyst Benjamin Theurer maintained a Buy rating on JBS today and set a price target of $21.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
- Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.
Theurer covers the Consumer Defensive sector, focusing on stocks such as Ingredion, Pilgrim’s Pride, and Tyson Foods. According to TipRanks, Theurer has an average return of 4.7% and a 52.24% success rate on recommended stocks.
JBS has an analyst consensus of Strong Buy, with a price target consensus of $18.87.
Based on JBS’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $111.47 billion and a net profit of $1.14 billion. In comparison, last year the company earned a revenue of $114.13 billion and had a net profit of $2.92 billion
Read More on JBS:
Disclaimer & DisclosureReport an Issue
- JBS N.V. Files Form 6-K and Publishes New Investor Presentation
- Largest borrow rate increases among liquid names
- Screwworm samples from Texas calves sent to lab for testing, Reuters says
- 2 High-Yield Dividend Stocks Paying 8%+ Passive Income, According to Analysts
- JBS Initiation: Russell Index Inclusions Seen Driving Passive Inflows, Narrowing Valuation Discount, and Supporting Buy Rating
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
